Hydralazine Injection
Last Updated: June 6, 2017
Status: Current
Hydralazine Injection
Products Affected - Description
-
Hydralazine injection, American Regent
20 mg/mL, 1 mL vial, 25 count (NDC 00517-0901-25)
Reason for the Shortage
-
- Akorn has hydralazine injection available.
- American Regent has hydralazine injection on shortage due to manufacturing delays. This product has not been available for several years.
- Fresenius Kabi has hydralazine injection available.
- X-Gen launched hydralazine injection in September 2015.
Available Products
-
Hydralazine injection, Akorn
20 mg/mL, 1 mL vial, 25 count (NDC 17478-0934-15)
Hydralazine injection, Fresenius Kabi
20 mg/mL, 1 mL vial, 25 count (NDC 63323-0614-01)
20 mg/mL, 1 mL vial, 25 count (NDC 63323-0614-01)
Hydralazine injection, X-Gen
20 mg/mL, 1 mL vial, 25 count (NDC 39822-0500-04)
20 mg/mL, 1 mL vial, 25 count (NDC 39822-0500-04)
Estimated Resupply Dates
-
- American Regent has hydralazine 20 mg/mL 1 mL vials on back order and the company cannot estimate a release date.
- All other marketed presentations are available.
Related Shortages
| Sodium Nitroprusside Injection | Current |
Updated
June 6, March 24, February 14, January 6, 2017; December 9, November 18, September 21, August 16, May 24, April 20, March 30 and 11, January 20, 2016; December 22, November 3, September 28 and 9, June 29, May 21, April 30, March 23, February 17, January 27 and 16, 2015; December 12, November 11, October 2, September 12, 2014, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
